FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA
Center | Date | Time | Location |
---|---|---|---|
NCTR | September 22, 2004 | 8 a.m. - 4:30 p.m. | Food and Drug
Administration |
Agenda:
The Air Force will present for review to The Ranch Hand Advisory Committee the
following chapters from the ongoing study: Chapter 19, ‘‘Immunology;’’
chapter 8, ‘‘Covariates;’’ chapter 12, ‘‘Psychology;’’
chapter 16, ‘‘Hematology;’’ chapter 15, ‘‘Cardiovascular;’’
chapter 7, ‘‘Statistical Methods;’’ chapter 5, ‘‘Study
Selection and Participation;’’ and chapter 18, ‘‘Endocrine.’’
Background material and meeting information will become available no later than one business day before the meeting (Simply select the appropriate committee link).
Procedure:
Interested persons may present data, information, or views, orally or in writing,
on issues pending before the committee. Written submissions may be made to the
contact person by September 20, 2004. Oral presentations from the public will
be scheduled between approximately 12:15 p.m. and 12:40 p.m. Time allotted for
each presentation may be limited. Those desiring to make formal oral presentations
should notify the contact person before September 20, 2004, and submit a brief
statement of the general nature of the evidence or arguments they wish to present,
the names and addresses of proposed participants, and an indication of the approximate
time requested to make their presentation. Persons attending FDA's advisory
committee meetings are advised that the agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the public at its advisory committee meetings
and will make every effort to accommodate persons with physical disabilities
or special needs. If you require special accommodations due to a disability,
please contact Leonard Schechtman at least 7 days in advance of the meeting.
Contact Person:
Leonard Schechtman, National Center for Toxicological Research,
Food and Drug Administration, 5600 Fishers Lane, Rm. 16–85, Rockville,
MD 20857, 301–827–6696, or FDA Advisory Committee Information Line,
1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512560. Please
call the Information Line for up-to-date information on this meeting.